From today's PR: "CytoDyn has successfully complet
Post# of 148171
(Total Views: 401)
Posted On: 04/13/2020 10:40:59 AM
From today's PR: "CytoDyn has successfully completed a Phase 3 pivotal trial with leronlimab in combination with standard antiretroviral therapies in HIV-infected treatment-experienced patients. CytoDyn plans to seek FDA approval for leronlimab in combination therapy and plans to complete the filing of a Biologics License Application (BLA) in April of 2020 for that indication. CytoDyn is also conducting a Phase 3 investigative trial with leronlimab as a once-weekly monotherapy for HIV-infected patients. CytoDyn plans to initiate a registration-directed study of leronlimab monotherapy indication."
(1)
(0)CytoDyn Inc (CYDY) Stock Research Links
Scroll down for more posts ▼